
Paul C. Nagle
Advertisement
Articles by Paul C. Nagle

Advertisement
Latest Updated Articles
Defining and Characterizing the Late-stage Biopharmaceutical PipelinePublished: October 1st 2003 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS
3
Intraarterial Alteplase After Thrombectomy May Improve Stroke Recovery: CHOICE2
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5



